
Ashley Taylor
Writer and Journalist at Freelance
Writer, journalist, essayist, et-ceter-ist. Words at @Hazlitt, @joylandfiction, @vol1brooklyn, @slc_lumina, @CatapultStory. Grad of Oberlin, NYU.
Articles
-
2 weeks ago |
cancertodaymag.org | Ashley Taylor
PATIENT-REPORTED OUTCOMES, or PROs, is a term that refers broadly to data reported by patients. Trials have found that, across cancer types, when people with advanced disease reported symptoms through a PRO-based system that alerted doctors to changes, they had better symptom management, fewer emergency room and hospital visits, longer survival and better quality of life than those who received usual care.
-
2 months ago |
patientpower.info | Ashley Taylor
If you are living with indolent systemic mastocytosis (ISM), you know how challenging the daily symptoms can be – from fatigue and brain fog to itching and digestive issues. However, there is encouraging news: The targeted therapy avapritinib (Ayvakit) is showing real-world success in helping patients like you feel better, regain control, and improve your quality of life (QoL). In 2023, the U.S. Food and Drug Administration (FDA) approved avapritinib as a treatment for ISM.
-
2 months ago |
cancertodaymag.org | Ashley Taylor
AT THE START of Quacks & Whacks: A Cancer Comedy, four singing puppets introduce themselves as cancer cells. They start in the lungs, hide from a biopsy needle, tell stories around a campfire, and then travel to the brain, their next campsite. These campy cancer cells, the audience learns, are inside the character of Sharon, a public school teacher who is diagnosed with metastatic lung cancer years after a lung biopsy comes up negative.
-
Mar 6, 2025 |
patientpower.info | Ashley Taylor |Liudmila Schafer
Jump ToPROs DataClinical TrialResultsCommentaryAdvocating for PRO SystemsBarriersAsking patients with metastatic cancer to monitor and report on their symptoms and well-being boosts quality of life and helps patients stay out of the emergency room (ER), according to a clinical trial called PRO-TECT. Surveying patients did not, however, improve overall survival, according to a report from the trial published February 7, 2025, in the journal Nature Medicine.
-
Oct 22, 2024 |
heraldextra.com | Ashley Taylor
By Ashley Taylor - Special to the Daily Herald | Oct 23, 2024 Stock photoThrough being vigilant with sun protection, regular screenings and healthy lifestyle choices, individuals with a genetic predisposition can reduce their risk of developing skin cancer.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 822
- Tweets
- 2K
- DMs Open
- No